4 things to know:
1. Double check the emergency health record or prescribing system to ensure the correct dosage. Before prescribing, refer to the FDA’s Paxlovid checklist for patient eligibility.
2. Don’t prescribe the treatment to patients with severe renal failure. Paxlovid is authorized for moderate renal impairment.
3. Avoid naming the regimen’s two pills, nirmatrelvir and ritonavir, by the packaging’s colors as this can lead to confusion.
4. The institute recommended Pfizer change the packaging on the renal dosing cartons to better differentiate the treatment from other Paxlovid packs.
